Nature Communications (Aug 2022)
Blocking ActRIIB and restoring appetite reverses cachexia and improves survival in mice with lung cancer
Abstract
Cancer-associated cachexia is characterized by loss of body weight, skeletal muscle and adipose tissue which relates to higher mortality in cancer patients. Here, the authors show in a lung cancer murine model that both ActRIIB signalling inhibition and restoring appetite are necessary to revert cachexia and improve survival in female mice.